Last reviewed · How we verify

NCT04326647: KT-DP

Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP)

Status unknown NA Last updated 30 March 2020
What this trial tests

NA trial testing Kinesiotaping in Parkinson Disease in 10 participants. Status unknown.

Timeline
1 July 2020
Primary endpoint
1 August 2020
1 August 2020

Quick facts

Lead sponsorUniversity of Castilla-La Mancha
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment10
Start date1 July 2020
Primary completion1 August 2020
Estimated completion1 August 2020
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Castilla-La Mancha

Who can join

Eligibility, any sex, with Parkinson Disease or Kinesiotaping. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To analyze the short-term effect of kinesiotaping in balance and gait on Parkinson's disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Kinesiotaping

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other University of Castilla-La Mancha trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04326647.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing